Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Int J Cardiol
    December 2025
  1. HINOJOSA W, Velazquez-Martin M, Coronel ML, Segura de la Cal T, et al
    Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertension.
    Int J Cardiol. 2025;441:133816.
    >> Share

    November 2025
  2. XU X, Liu Z, Liu Z, Li Z, et al
    Increased sympathetic outflow induced by ventromedial hypothalamic nucleus activation aggravates cardiac electrophysiology disturbance after myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2025;439:133634.
    >> Share

  3. ANAGNOSTOPOULOS I, Vrachatis D, Kousta M, Giotaki S, et al
    Early catheter ablation versus conservative- only management in patients with electrical storm. Systematic review and meta- analysis.
    Int J Cardiol. 2025;438:133597.
    >> Share

    September 2025
  4. MATSUOKA Y, Sakamoto D, Sunaga A, Okada K, et al
    Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants.
    Int J Cardiol. 2025;443:133942.
    >> Share

  5. OKUYAMA T
    Response to a comment re: "Impact of diagnosis-to-ablation time (DAT) on rhythm outcomes after catheter ablation for atrial fibrillation (AF)".
    Int J Cardiol. 2025 Sep 11:133892. doi: 10.1016/j.ijcard.2025.133892.
    >> Share

  6. LU Y, Liu Y, Zhang Y, Wang H, et al
    Global burden of early-onset atrial fibrillation and flutter: Population based study.
    Int J Cardiol. 2025 Sep 6:133862. doi: 10.1016/j.ijcard.2025.133862.
    >> Share

  7. VELT MJH, Mulder BA
    Reply to letters to the editor part 1: Duration of atrial fibrillation and cardiac biomarkers: Data from the RACE II study.
    Int J Cardiol. 2025 Sep 2:133849. doi: 10.1016/j.ijcard.2025.133849.
    >> Share

  8. VELT MJH, Mulder BA
    Reply to letters to the editor part 2: Duration of atrial fibrillation and cardiac biomarkers: Data from the RACE II study.
    Int J Cardiol. 2025 Sep 1:133850. doi: 10.1016/j.ijcard.2025.133850.
    >> Share

    August 2025
  9. SHAWKI M, Sampaio Rodrigues T, Khabazi KP, Brick C, et al
    Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis.
    Int J Cardiol. 2025;442:133846.
    >> Share

  10. CHONAN Y, Suzuki H, Takeuchi K, Takanami K, et al
    Insular abnormalities in (18)F-fluorodeoxyglucose positron emission tomography and risk of fatal ventricular arrhythmic events in patients with cardiac sarcoidosis.
    Int J Cardiol. 2025;441:133814.
    >> Share

  11. YU H
    Letter to editor: Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025 Aug 9:133761. doi: 10.1016/j.ijcard.2025.133761.
    >> Share

  12. LIU X, Zhang Y
    Comment on:"Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study".
    Int J Cardiol. 2025 Aug 7:133741. doi: 10.1016/j.ijcard.2025.133741.
    >> Share

  13. ZHANG L, Luo Z, Lin R
    Comment on"impact of diagnosis-to-ablation time on rhythm outcome after catheter ablation for paroxysmal versus non-paroxysmal atrial fibrillation".
    Int J Cardiol. 2025 Aug 7:133735. doi: 10.1016/j.ijcard.2025.133735.
    >> Share

  14. LOHANO G, Lohano G, Das R, Lohana S, et al
    Letter to the editor: Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025 Aug 6:133728. doi: 10.1016/j.ijcard.2025.133728.
    >> Share

  15. HUA W, Qiao F, Tang W
    Comment on duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025 Aug 6:133727. doi: 10.1016/j.ijcard.2025.133727.
    >> Share

  16. SU Z, Zhang P, He Z
    Association between atrial fibrillation duration, cardiac biomarkers, and cardiovascular outcomes in early permanent atrial fibrillation.
    Int J Cardiol. 2025 Aug 6:133733. doi: 10.1016/j.ijcard.2025.133733.
    >> Share

  17. SHAMSULDDIN AB
    Beyond time alone: Reframing the definition of permanent atrial fibrillation with biomarkers.
    Int J Cardiol. 2025 Aug 5:133720. doi: 10.1016/j.ijcard.2025.133720.
    >> Share

  18. DHANKA S, Maini S
    A hybrid machine learning approach using particle swarm optimization for cardiac arrhythmia classification.
    Int J Cardiol. 2025;432:133266.
    >> Share

    July 2025
  19. VELT MJH, van Gelder IC, Crijns HJGM, Rienstra M, et al
    Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025;439:133669.
    >> Share

  20. OKUYAMA T, Watanabe T, Hoshide S, Suda N, et al
    Impact of diagnosis-to-ablation time on rhythm outcome after catheter ablation for paroxysmal versus non-paroxysmal atrial fibrillation.
    Int J Cardiol. 2025;439:133667.
    >> Share

  21. MALANCHINI G, Celentano E
    Reply to Comment on "Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter defibrillators: A propensity score-matched analysis".
    Int J Cardiol. 2025;439:133619.
    >> Share

  22. GAO S, Yan Y, Liu L
    Navigating pharmacotherapy in heart failure complicated by atrial fibrillation: A practical summary.
    Int J Cardiol. 2025;439:133640.
    >> Share

  23. GUELI IA, Aimo A, Alderotti B, Trimarchi G, et al
    Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2025;431:133224.
    >> Share

  24. ZHANG J, Wang L, Li Y, Li Q, et al
    Atrial fibrillation phenotypes identified through cluster analysis in the CABANA study.
    Int J Cardiol. 2025;438:133606.
    >> Share

  25. MAGNANI JW, Plevniak K, Ferry D, Martin D, et al
    The mobile health intervention for rural patients with atrial fibrillation a randomized controlled trial.
    Int J Cardiol. 2025 Jul 1:133575. doi: 10.1016/j.ijcard.2025.133575.
    >> Share

    June 2025
  26. MERT GO, Spartalis M, Murat S, Gorenek B, et al
    Commentary on ventricular arrhythmias in acute heart failure: Critical insights into the 2024 ESC-EHRA-ACVC-HFA consensus.
    Int J Cardiol. 2025 Jun 24:133544. doi: 10.1016/j.ijcard.2025.133544.
    >> Share

  27. THANGJUI S, Trongtorsak A, Kewcharoen J, Balla S, et al
    Post-cardioversion anticoagulation in atrial fibrillation with left atrial appendage occlusion: Necessary or not?
    Int J Cardiol. 2025;438:133518.
    >> Share

  28. LONG X, Li J
    Letter to the editor: Independent effect of influenza vaccination on all-cause mortality in critically ill patients with atrial fibrillation: A retrospective study from the MIMIC-IV database.
    Int J Cardiol. 2025;437:133502.
    >> Share

  29. LONG X
    Comment on "Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis".
    Int J Cardiol. 2025;437:133501.
    >> Share

  30. SU B, Zhao J, Dai X, Ma C, et al
    A novel algorithm based on left atrial strain parameters in patients with non-valvular atrial fibrillation could identify the thrombogenic milieu of left atrial appendage.
    Int J Cardiol. 2025;437:133498.
    >> Share

  31. DILAVERIS P, Siasos G
    Nationwide, Danish data may assist in refining ischemic stroke risk prediction in atrial fibrillation.
    Int J Cardiol. 2025;437:133460.
    >> Share

  32. SHIMADA T, Fukuda D, Shibata A, Ito A, et al
    Risk stratification of net adverse clinical events using CHADS-P(2)A(2)RC and CHADS(2) scores in chronic coronary syndrome patients without atrial fibrillation: Insights from the CLIDAS-PCI.
    Int J Cardiol. 2025;437:133464.
    >> Share

  33. LAZZARI L, Donzelli S, Marallo C, Tordini A, et al
    Development and validation of an ECG algorithm based on lead V3 morphology to determine the origin of outflow tract ventricular arrhythmias.
    Int J Cardiol. 2025;436:133446.
    >> Share

    May 2025
  34. LIU ZB, Wang Y, Liu J, Ding SF, et al
    Combination of colchicine and bifidobacteria: A promising strategy for reducing the recurrence of atrial fibrillation.
    Int J Cardiol. 2025 May 27:133440. doi: 10.1016/j.ijcard.2025.133440.
    >> Share

  35. ZHAO P, Zhang T
    Letter to "U-shaped relationship between serum phosphate levels and mortality in critically ill patients with atrial fibrillation: Insights from the MIMIC-IV database".
    Int J Cardiol. 2025 May 27:133430. doi: 10.1016/j.ijcard.2025.133430.
    >> Share

  36. AKKAYA F, Hosoglu Y
    Is female sex still a driver of stroke risk in atrial fibrillation?
    Int J Cardiol. 2025 May 27:133442. doi: 10.1016/j.ijcard.2025.133442.
    >> Share

  37. SONG Y, Li M, Zhang Z
    Comment on "impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes".
    Int J Cardiol. 2025 May 27:133441. doi: 10.1016/j.ijcard.2025.133441.
    >> Share

  38. CERSOSIMO A, Arabia G, Cerini M, Calvi E, et al
    Predictive value of left and right atrial strain for the detection of device-detected atrial fibrillation in patients with cryptogenic stroke and implantable cardiac monitor.
    Int J Cardiol. 2025 May 21:133368. doi: 10.1016/j.ijcard.2025.133368.
    >> Share

  39. ZHOU M, Chen J, Behera TR, Shen Q, et al
    Editorial: Phosphate paradox: The U-shaped mortality curve in critically ill patients with atrial fibrillation.
    Int J Cardiol. 2025;435:133399.
    >> Share

  40. BASEM M, Bonnesen K, Szentkuti P, Horvath-Puho E, et al
    Interaction between atrial fibrillation or flutter and the CHA(2)DS(2)-VASc score on the risk of ischemic stroke: A population-based cohort study.
    Int J Cardiol. 2025;435:133397.
    >> Share

  41. LIU ZB, Lu Q, Liu J, Ding SF, et al
    Combination of colchicine and berberine for reducing atrial fibrillation recurrence post-ablation and preventing postoperative atrial fibrillation: A promising approach?
    Int J Cardiol. 2025;435:133393.
    >> Share

  42. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Response to SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025 May 15:133396. doi: 10.1016/j.ijcard.2025.133396.
    >> Share

  43. YICHI Y, Xiaomin Y, Jian S, Pengpai Z, et al
    Routine preoperative transthoracic echocardiography for predicting incomplete endothelialization of the watchman left atrial appendage occluder: A single-center five-year study.
    Int J Cardiol. 2025 May 15:133385. doi: 10.1016/j.ijcard.2025.133385.
    >> Share

  44. SHEN J, Ge L, Chen L, Qiu B, et al
    Left atrial low voltage areas predicts clinical stroke after radiofrequency ablation in patients with atrial fibrillation.
    Int J Cardiol. 2025 May 11:133366. doi: 10.1016/j.ijcard.2025.133366.
    >> Share

  45. TUKKER M, Te Rijdt WP, Amin AS, Morris-Rosendahl DJ, et al
    High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature.
    Int J Cardiol. 2025 May 6:133350. doi: 10.1016/j.ijcard.2025.133350.
    >> Share

    April 2025
  46. MALANCHINI G, Celentano E, Curnis A, Rovaris G, et al
    Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis.
    Int J Cardiol. 2025;433:133323.
    >> Share

  47. FAN ZX, Huang YF
    Targeting the SPP1/TGF-beta1 axis in macrophages: A potential therapeutic mechanism for atrial fibrillation?
    Int J Cardiol. 2025;433:133312.
    >> Share

  48. JUNGEN C, Mathew S
    Advancing the treatment of persistent atrial fibrillation - Lessons from vein of Marshall ethanol infusion.
    Int J Cardiol. 2025 Apr 17:133271. doi: 10.1016/j.ijcard.2025.133271.
    >> Share

  49. HE Y, Huang J, Huang S, Li Y, et al
    U-shaped relationship between serum phosphate levels and mortality in critically ill patients with atrial fibrillation: Insights from the MIMIC-IV database.
    Int J Cardiol. 2025 Apr 15:133283. doi: 10.1016/j.ijcard.2025.133283.
    >> Share

  50. LEI J, Zheng LZ, Chen KY, Yang X, et al
    Independent effect of influenza vaccination on all-cause mortality in critically ill patients with atrial fibrillation: A retrospective study from the MIMIC-IV database.
    Int J Cardiol. 2025;433:133246.
    >> Share

  51. LEE JH, Lee SR, Cho Y, Oh IY, et al
    Clinical outcomes associated with Insertable cardiac monitor implantation in Korea: A Nationwide claims data analysis.
    Int J Cardiol. 2025;432:133265.
    >> Share

    March 2025
  52. FAN ZX, Wu JC, Yang J
    SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025;430:133206.
    >> Share

  53. YANG L, Yuan Z, Chen Y, Zeng Y, et al
    Plasma expression level of Hsa_circ_0099734 is associated with atrial fibrillation and its poor prognosis.
    Int J Cardiol. 2025 Mar 24:133202. doi: 10.1016/j.ijcard.2025.133202.
    >> Share

  54. CESARO A, Acerbo V, Gragnano F, Calabro P, et al
    SGLT2 Inhibitors in atrial fibrillation: Ready for prime time?
    Int J Cardiol. 2025;430:133186.
    >> Share

  55. YANG J, He L, Yuan D
    A new predictive tool of ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
    Int J Cardiol. 2025;430:133190.
    >> Share

  56. SCHIANO C, Infante T, Benincasa G, Burrello J, et al
    DNA hypermethylation of MED1 and MED23 as early diagnostic biomarkers for unsolved issues in atrial fibrillation.
    Int J Cardiol. 2025 Mar 18:133179. doi: 10.1016/j.ijcard.2025.133179.
    >> Share

  57. HAYASHI Y, Igarashi M, Yamasaki H, Iioka Y, et al
    Impact of radiofrequency versus cryoballoon ablation on left atrial calcification after atrial fibrillation ablation: A propensity score-matched comparison.
    Int J Cardiol. 2025 Mar 18:133177. doi: 10.1016/j.ijcard.2025.133177.
    >> Share

  58. LUO B, Ma Z, Liu X, Liu T, et al
    Long-term effects of catheter ablation with vein of Marshall ethanol infusion vs. pulmonary vein isolation alone on persistent atrial fibrillation.
    Int J Cardiol. 2025 Mar 14:133130. doi: 10.1016/j.ijcard.2025.133130.
    >> Share

  59. CHEN S, Liu Q, Yin X, Xiao F, et al
    12-month outcomes of pulsed-field ablation with a variable-diameter circular catheter for paroxysmal atrial fibrillation: Insights into conscious sedation and fluoroscopy use.
    Int J Cardiol. 2025 Mar 10:133135. doi: 10.1016/j.ijcard.2025.133135.
    >> Share

  60. HU Y, Li C, Li Y, Wu X, et al
    Steps to improve the outcome of a single ablation procedure for paroxysmal atrial fibrillation: Significance of a burst stimulation-guided ablation strategy.
    Int J Cardiol. 2025;428:133132.
    >> Share

  61. LIANG E, Kang L, Song W, Du Z, et al
    Vagal response during radiofrequency catheter ablation initiated from right superior pulmonary vein: Incidence, risk factors, and clinical outcomes.
    Int J Cardiol. 2025;422:132915.
    >> Share

    February 2025
  62. FAN ZX, Xu XF, Yang CJ
    Combination of colchicine and omega-3 fatty acids for reducing the recurrence of atrial fibrillation: A promising approach?
    Int J Cardiol. 2025;426:133100.
    >> Share

  63. AMEER MZ, Rehman AU, Amjad Z, Khan S, et al
    Cardiovascular outcomes with SGLT-2 inhibitors in individuals with diabetes and co-existing atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2025;426:133083.
    >> Share

  64. OZLEK B, Barutcu S, Prof A
    Colchicine and post-ablation atrial fibrillation recurrence: How effective is it?
    Int J Cardiol. 2025;426:133089.
    >> Share

  65. DELL'ERA G, Palmisano P, Bertini M, Magnano M, et al
    Real-world adoption of left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING).
    Int J Cardiol. 2025;421:132879.
    >> Share

  66. OUCHI K, Sakuma T, Kisaki S, Tokutake K, et al
    Left atrial changes and B-type natriuretic peptide levels after pulmonary vein isolation for atrial fibrillation.
    Int J Cardiol. 2025;425:133053.
    >> Share

  67. GAO X, Xie B, Zhao Z, Chen K, et al
    Reply to Letter to the Editor for the "NSUN2/PARP1 signaling axis: A potential mechanism for treating aging associated atrial fibrillation".
    Int J Cardiol. 2025 Feb 4:133042. doi: 10.1016/j.ijcard.2025.133042.
    >> Share

    January 2025
  68. YETKIN E
    Recurrence of atrial fibrillation: Low dose colchicine and allopurinol.
    Int J Cardiol. 2025 Jan 27:133013. doi: 10.1016/j.ijcard.2025.133013.
    >> Share

  69. FENDER AC, Bruns F, Dobrev D
    Sex and atrial fibrillation-associated risk estimation and management.
    Int J Cardiol. 2025;423:133000.
    >> Share

  70. FAN ZX, Yang J
    NSUN2/PARP1 signaling axis: A potential mechanism for treating aging-associated atrial fibrillation.
    Int J Cardiol. 2025;422:132993.
    >> Share

  71. CASULA M, Scajola LV, Quilico F, Pasotti B, et al
    Posterior left atrial wall isolation for treatment of persistent atrial fibrillation during first-time catheter ablation: An updated systematic review and meta-analysis.
    Int J Cardiol. 2025;422:132987.
    >> Share

  72. GRANCHIETTI AG, Ciardetti N, Mazzoni C, Garofalo M, et al
    Left atrial strain and risk of atrial fibrillation after coronary artery bypass-grafting.
    Int J Cardiol. 2025;422:132981.
    >> Share

  73. AL-SADAWI M, Aslam F, Henriques MD, Alsaiqali M, et al
    Effect of low dose colchicine on long term recurrence after atrial fibrillation ablation.
    Int J Cardiol. 2025 Jan 8:132972. doi: 10.1016/j.ijcard.2025.132972.
    >> Share

  74. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes.
    Int J Cardiol. 2025 Jan 2:132954. doi: 10.1016/j.ijcard.2024.132954.
    >> Share

    December 2024
  75. GARCIA OO, de la Fuente-Lopez P, Cinza-Sanjurjo S, Cordero A, et al
    Gender-specific effects of delay in cardiology consultation following primary care physician referral in atrial fibrillation patients: Impact on one-year outcomes.
    Int J Cardiol. 2024 Dec 30:132947. doi: 10.1016/j.ijcard.2024.132947.
    >> Share

  76. JASON MJ, Marzec LN, Piccini JP, Shrader P, et al
    Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry.
    Int J Cardiol. 2024 Dec 19:132912. doi: 10.1016/j.ijcard.2024.132912.
    >> Share

  77. DE SIO V, Gragnano F, Capolongo A, Terracciano F, et al
    Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions.
    Int J Cardiol. 2024 Dec 19:132921. doi: 10.1016/j.ijcard.2024.132921.
    >> Share

  78. WANG G, Liu T, Ji W, Wang N, et al
    Prolonged elevated heart rate is association with adverse outcome in severe pulmonary embolism: A retrospective study.
    Int J Cardiol. 2024;417:132581.
    >> Share

  79. LOPEZ J, Duarte G, Mark JD, Vergara Sanchez C, et al
    Impact of cardiac conduction disease in patients with cardiac amyloidosis: A national retrospective cohort study.
    Int J Cardiol. 2024;417:132468.
    >> Share

  80. DAMIANI D, Agosta VT, D'Andria Ursoleo J, Bottussi A, et al
    Perioperative and long-term outcomes of bilateral cardiac sympathetic denervation via video-assisted thoracoscopic surgery in patients with refractory ventricular arrhythmias.
    Int J Cardiol. 2024;421:132890.
    >> Share

  81. CALIK KUTUKCU E
    The one-minute sit-to-stand test: A novel tool for assessing functional capacity in patients with atrial fibrillation.
    Int J Cardiol. 2024;421:132896.
    >> Share

  82. CESMAT AP, Chaudry AM, Gupta S, Weickert TT, et al
    Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
    Int J Cardiol. 2024;421:132888.
    >> Share

  83. PREDA A, Falasconi G, Melillo F, Margonato D, et al
    Left atrial appendage closure in patients with failure of anticoagulation therapy: A multicenter comparative study on the hybrid strategy using DOACs and VKAs.
    Int J Cardiol. 2024;421:132875.
    >> Share

  84. CAMM CJF, Virdone S, Jerjes-Sanchez C, Oh S, et al
    Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry.
    Int J Cardiol. 2024 Dec 2:132866. doi: 10.1016/j.ijcard.2024.132866.
    >> Share

    November 2024
  85. LIONCINO M, Placidi S, Calcagni G, Drago F, et al
    Reply: Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
    Int J Cardiol. 2024 Nov 18:132732. doi: 10.1016/j.ijcard.2024.132732.
    >> Share

  86. XU B, Wang Y, Zhao C, Yu Z, et al
    Identifying left atrium and left atrial appendage prone to thrombus formation in patients with atrial fibrillation using statistical shape modeling.
    Int J Cardiol. 2024 Nov 17:132731. doi: 10.1016/j.ijcard.2024.132731.
    >> Share

  87. NEDIOS S, Arentz T
    Navigating pregnancy: Considerations for ablating atrial tachycardias.
    Int J Cardiol. 2024;415:132474.
    >> Share

  88. LAURSEN SB, Pareek M, Polcwiartek C, Kristensen AMD, et al
    High-sensitivity cardiac troponin-T concentrations and their prognostic implications in patients with paroxysmal supraventricular tachycardia.
    Int J Cardiol. 2024 Nov 14:132717. doi: 10.1016/j.ijcard.2024.132717.
    >> Share

  89. KAWAJI T, Hamatani Y, Kato M, Yokomatsu T, et al
    Bundle branch block patterns during atrial fibrillation rhythm for heart failure events.
    Int J Cardiol. 2024 Nov 9:132710. doi: 10.1016/j.ijcard.2024.132710.
    >> Share

  90. OZEL CB, Ozdemir HY, Dural M, Al A, et al
    The one-minute sit-to-stand test is an alternative to the 6-minute walk test in patients with atrial fibrillation: A cross-sectional study and ROC curve analysis.
    Int J Cardiol. 2024 Nov 7:132713. doi: 10.1016/j.ijcard.2024.132713.
    >> Share

  91. SCHINDLER TH, Eslambolchi A, Ozkan E
    Mild basal interventricular inflammation as a predictor of ventricular arrhythmia?
    Int J Cardiol. 2024;419:132715.
    >> Share

    October 2024
  92. TAKEUCHI K, Suzuki H, Takanami K, Ota H, et al
    Reduced (18)F-FDG uptake in the basal interventricular septum as a predictor of fatal ventricular arrhythmic events in patients with cardiac sarcoidosis.
    Int J Cardiol. 2024 Oct 25:132686. doi: 10.1016/j.ijcard.2024.132686.
    >> Share

  93. DEL FRANCO A, Argiro A, Bonacchi G, Cappelli F, et al
    Left ventricular late gadolinium enhancement for prediction of atrial fibrillation in hypertrophic cardiomyopathy: A good neighbour warns of the danger.
    Int J Cardiol. 2024;419:132662.
    >> Share

  94. CHEN M, Pang B, Li G, Wang Y, et al
    Predictive value of apical rocking and septal flash for subclinical left ventricular systolic dysfunction in complete left bundle branch block patients with normal left ventricular ejection fraction.
    Int J Cardiol. 2024 Oct 24:132683. doi: 10.1016/j.ijcard.2024.132683.
    >> Share

  95. MINAMI K, Machino-Ohtsuka T, Nakatsukasa T, Kawamatsu N, et al
    Clinical significance of echocardiographic left ventricular hypertrophy for predicting left atrial appendage thrombotic milieu in patients with atrial fibrillation and CHA(2)DS(2)-VASc scores of 0-2.
    Int J Cardiol. 2024;419:132682.
    >> Share

  96. LIU Y, Dai W
    Letter to the Editor: Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
    Int J Cardiol. 2024 Oct 22:132679. doi: 10.1016/j.ijcard.2024.132679.
    >> Share

  97. VENTRELLA N, Schiavone M, Bianchini L, Sicuso R, et al
    Catheter ablation for focal atrial tachycardias during pregnancy: A systematic review.
    Int J Cardiol. 2024;413:132333.
    >> Share

  98. ARABIA G, Colangelo M, Borrello F, Curnis A, et al
    Usefulness of last generation insertable cardiac monitors in the diagnosis of unexplained syncope.
    Int J Cardiol. 2024;413:132301.
    >> Share

  99. LI G, Ma Z, Lu Y, Jiang Y, et al
    Associations of socioeconomic status and chronic stress with incident atrial fibrillation among older adults: A prospective cohort study from the UK biobank.
    Int J Cardiol. 2024;418:132633.
    >> Share

  100. GAROT P, Gall E, Zendjebil S, Cepas-Guillen P, et al
    Left atrial appendage closure guided by fusion of 3D computational modelling on real-time fluoroscopy: A multicenter experience.
    Int J Cardiol. 2024;418:132614.
    >> Share

  101. YAN Z, Pu X, Chang X, Liu Z, et al
    Genetic basis and causal relationship between atrial fibrillation and sinus node dysfunction: Evidence from comprehensive genetic analysis.
    Int J Cardiol. 2024 Oct 8:132609. doi: 10.1016/j.ijcard.2024.132609.
    >> Share

  102. VELT MJH, Rienstra M, Mulder BA
    Reply to: Biomarkers in paroxysmal atrial fibrillation during an acute episode: The cause or the result?
    Int J Cardiol. 2024;418:132622.
    >> Share

  103. NIELSEN-KUDSK JE, Korsholm K, Andersen A, Jensen JM, et al
    Real changes in left atrial appendage occlusion practice in Denmark over time or inappropriate use of registry data?
    Int J Cardiol. 2024;412:132350.
    >> Share

  104. BASILE P, Soldato N, Pedio E, Siena P, et al
    Cardiac magnetic resonance reveals concealed structural heart disease in patients with frequent premature ventricular contractions and normal echocardiography: A systematic review.
    Int J Cardiol. 2024;412:132306.
    >> Share

  105. CLEMENTE MRC, Navalha DDP, Bittar V, Costa TA, et al
    Combined left atrial appendage occlusion and catheter ablation for atrial fibrillation versus isolated left atrial appendage occlusion: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Oct 1:132597. doi: 10.1016/j.ijcard.2024.132597.
    >> Share

    September 2024
  106. PLACIDI S, Calcagni G, Lioncino M, Calvieri C, et al
    Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
    Int J Cardiol. 2024 Sep 24:132599. doi: 10.1016/j.ijcard.2024.132599.
    >> Share

  107. XIAO X
    Biomarkers in paroxysmal atrial fibrillation during an acute episode: The cause or the result?
    Int J Cardiol. 2024 Sep 19:132589. doi: 10.1016/j.ijcard.2024.132589.
    >> Share

  108. XIAO X
    Fibroblast growth factor 5: A novel and promising therapeutic target in atrial fibrillation.
    Int J Cardiol. 2024 Sep 19:132586. doi: 10.1016/j.ijcard.2024.132586.
    >> Share

  109. MIYAMOTO S, Tokuyama T, Okubo Y, Okamura S, et al
    Decreased plasma cell-free mitochondrial DNA may be a new biomarker of tachycardia-induced cardiomyopathy in patients with atrial fibrillation.
    Int J Cardiol. 2024 Sep 19:132579. doi: 10.1016/j.ijcard.2024.132579.
    >> Share

  110. BOTTO GL, Capranzano P, Colonna P, Fornasari DMM, et al
    Use of DOACs in frail elderly patients in light of class genericization.
    Int J Cardiol. 2024;411:132276.
    >> Share

  111. YAFASOV M, Olsen FJ, Hauser R, Skaarup KG, et al
    Left atrial strain measured by three-dimensional echocardiography predicts atrial fibrillation in the general population.
    Int J Cardiol. 2024;417:132544.
    >> Share

  112. AKDIS D, Weidmann L, Guan F, Bachmann M, et al
    Clinical experience of pulmonary vein isolation via single transseptal puncture in atrial fibrillation patients: Comprehensive characterization and follow-up.
    Int J Cardiol. 2024 Sep 12:132557. doi: 10.1016/j.ijcard.2024.132557.
    >> Share

  113. TACHIBANA S, Inaba O, Inamura Y, Takagi T, et al
    Segmental evaluation of predictive value of left atrial epicardial adipose tissue following catheter ablation for atrial fibrillation.
    Int J Cardiol. 2024;417:132558.
    >> Share

  114. MENE R, Sousonis V, Schmidt B, Bordignon S, et al
    Safety and efficacy of pulsed-field ablation for atrial fibrillation in the elderly: A EU-PORIA sub-analysis.
    Int J Cardiol. 2024;417:132522.
    >> Share

  115. LAN Z, Cheng S, Han Y, Jiang L, et al
    Predictive value of fine fibrillatory wave for declining eGFR in patients with persistent atrial fibrillation: Long-term follow-up study.
    Int J Cardiol. 2024;417:132521.
    >> Share

  116. VELT MJH, Crijns HJGM, van Gelder IC, Linz D, et al
    Dynamic biomarker profiles in patients with paroxysmal atrial fibrillation: Assessing the differences between sinus rhythm and acute atrial fibrillation episode.
    Int J Cardiol. 2024;417:132526.
    >> Share

  117. WAFA SEI, Sawatari H, Ahmed R, Deshpande S, et al
    CHA(2)DS(2)-VASc predicts readmission, outcomes and resource utilization in patients undergoing coronary artery bypass grafting: A 7-year National Readmission Database study.
    Int J Cardiol. 2024 Sep 5:132529. doi: 10.1016/j.ijcard.2024.132529.
    >> Share

  118. JUNG M, Kim SW, Park JW
    Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013-2021: A nationwide observational study.
    Int J Cardiol. 2024;410:132222.
    >> Share

    August 2024
  119. FAN K, Xiao Y, Xue A, Zhou J, et al
    Clinical outcomes, management, healthcare resource utilization, and cost according to the CHA(2)DS(2)-VASc scores in Asian patients with nonvalvular atrial fibrillation.
    Int J Cardiol. 2024 Aug 28:132496. doi: 10.1016/j.ijcard.2024.132496.
    >> Share

  120. LIU T, Yang X, Jia R, Han J, et al
    Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
    Int J Cardiol. 2024 Aug 26:132480. doi: 10.1016/j.ijcard.2024.132480.
    >> Share

  121. PALARETI G, Testa S, Legnani C, Paoletti O, et al
    The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events.
    Int J Cardiol. 2024 Aug 24:132484. doi: 10.1016/j.ijcard.2024.132484.
    >> Share

  122. WEI Z, Lu Y, Qian C, Li J, et al
    Circ_0079480 facilitates proliferation, migration and fibrosis of atrial fibroblasts in atrial fibrillation by sponing miR-338-3p to activate the THBS1/TGF-beta1/Smad3 signaling.
    Int J Cardiol. 2024 Aug 24:132486. doi: 10.1016/j.ijcard.2024.132486.
    >> Share

  123. WU S, Shang W, Ye Y, Su L, et al
    Sex differences outcomes in conduction system pacing for patients with typical left bundle branch block.
    Int J Cardiol. 2024 Aug 22:132475. doi: 10.1016/j.ijcard.2024.132475.
    >> Share

  124. DURAK H, Ergul E
    Association of induced atrial fibrillation in the electrophysiology laboratory with endothelial dysfunction and documented atrial fibrillation.
    Int J Cardiol. 2024;415:132465.
    >> Share

  125. ROMANOV A, Nikitin N
    Epicardial adipose tissue for atrial arrhythmias prediction in coronary artery disease. Are we close to the gold marker?
    Int J Cardiol. 2024;409:132176.
    >> Share

  126. PICCOLO S, Casal M, Rossi V, Ferrigni F, et al
    Ventricular arrhythmias and primary prevention of sudden cardiac death in Anderson-Fabry disease.
    Int J Cardiol. 2024;415:132444.
    >> Share

  127. JIANG L, Zhang X, Ding SA, Tang M, et al
    Simultaneous thoracoscopic surgery in patients with atrial fibrillation and early-stage lung cancer.
    Int J Cardiol. 2024 Aug 2:132422. doi: 10.1016/j.ijcard.2024.132422.
    >> Share

    July 2024
  128. BALL J, Mahony E, Nehme E, Voskoboinik A, et al
    The burden of atrial fibrillation on emergency medical services: A population-based cohort study.
    Int J Cardiol. 2024 Jul 29:132397. doi: 10.1016/j.ijcard.2024.132397.
    >> Share

  129. GAO C, Wang W, Jia H
    Fibroblast growth factor 5 as a target for atrial fibrillation treatment: Evidence from mendelian randomization.
    Int J Cardiol. 2024;413:132393.
    >> Share

  130. ANDREA B, Anna D, Daniele B, Angelica C, et al
    H(2)FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation.
    Int J Cardiol. 2024 Jul 18:132385. doi: 10.1016/j.ijcard.2024.132385.
    >> Share

  131. AMANO M, Takegami M, Miyake M, Kitai T, et al
    Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation.
    Int J Cardiol. 2024 Jul 16:132375. doi: 10.1016/j.ijcard.2024.132375.
    >> Share

  132. ZHANG Z, Xiao Y, Wang C, Zhou J, et al
    Pulsed field ablation: A promising approach for ventricular tachycardia ablation.
    Int J Cardiol. 2024;407:131985.
    >> Share

  133. ZHANG X, Zhang Y, Sun G, Li Z, et al
    Effectiveness of sodium-glucose co-transporter 2 inhibitors on atrial fibrillation recurrence after catheter ablation: A systemic review and meta-analysis.
    Int J Cardiol. 2024;413:132359.
    >> Share

  134. ALBANI S, Merlo M
    Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
    Int J Cardiol. 2024;413:132357.
    >> Share

  135. GIOMI A, Bernardini A, Perini AP, Ciliberti D, et al
    Clinical impact of smoking on atrial fibrillation recurrence after pulmonary vein isolation.
    Int J Cardiol. 2024 Jul 4:132342. doi: 10.1016/j.ijcard.2024.132342.
    >> Share

  136. HEEGER CH, Alagjozovski H
    Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
    Int J Cardiol. 2024;412:132299.
    >> Share

  137. GU Z, Guo L, Liu C, Lip GYH, et al
    Real-world evidence of early rhythm control in patients with atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Jul 2:132327. doi: 10.1016/j.ijcard.2024.132327.
    >> Share

  138. TERSALVI G, Bossard M, Aeschbacher S, Wiencierz A, et al
    Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
    Int J Cardiol. 2024 Jul 2:132320. doi: 10.1016/j.ijcard.2024.132320.
    >> Share

  139. REN Y, Chen L, Liu J, Wu Y, et al
    Correlation of epicardial adipose tissue and inflammatory indices in patients with STEMI and implications for atrial arrhythmias.
    Int J Cardiol. 2024;406:132016.
    >> Share

    June 2024
  140. DAN GA
    Resurrection of classical antiarrhythmic drugs.
    Int J Cardiol. 2024;412:132300.
    >> Share

  141. VIJ V, Ruf TF, Thambo JB, Vogt L, et al
    Contrast-free left atrial appendage occlusion in patients using the LAMBRE device.
    Int J Cardiol. 2024;405:131939.
    >> Share

  142. WANG SR, Huang KC, Lin TT, Chuang SL, et al
    Corrigendum to "The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease" [International Journal of Cardiology 409 (2024) 132198].
    Int J Cardiol. 2024;411:132257.
    >> Share

  143. HOLLOWELL M, Banno J, Marsy D, Shrestha N, et al
    Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024 Jun 13:132263. doi: 10.1016/j.ijcard.2024.132263.
    >> Share

  144. BERNARDINI A, Bindini L, Antonucci E, Berteotti M, et al
    Corrigendum to "Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation" [International Journal of Cardiology 407 (2024) 132088].
    Int J Cardiol. 2024 Jun 8:132226. doi: 10.1016/j.ijcard.2024.132226.
    >> Share

  145. SUNAGA A, Matsuoka Y, Nakatani D, Okada K, et al
    Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
    Int J Cardiol. 2024 Jun 3:132231. doi: 10.1016/j.ijcard.2024.132231.
    >> Share

  146. KAUR H, Tao B, Silverman M, Healey JS, et al
    Recurrence of new-onset post-operative AF after cardiac surgery: detected by implantable loop recorders: A systematic review and Meta-analysis.
    Int J Cardiol. 2024;404:131930.
    >> Share

    May 2024
  147. WAZZAN AAL, Taconne M, Rolle VL, Forsaa MI, et al
    Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
    Int J Cardiol. 2024 May 24:132167. doi: 10.1016/j.ijcard.2024.132167.
    >> Share

  148. RELLA V, Maurizi N, Bernardini A, Brasca FM, et al
    Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2024 May 23:132202. doi: 10.1016/j.ijcard.2024.132202.
    >> Share

  149. WANG SR, Huang KC, Lin TT, Chuang SL, et al
    The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
    Int J Cardiol. 2024 May 21:132198. doi: 10.1016/j.ijcard.2024.132198.
    >> Share

  150. UKITA K, Egami Y, Yano M, Nishino M, et al
    Reply to "Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?".
    Int J Cardiol. 2024;409:132187.
    >> Share

  151. MALHI JK, Ibecheozor C, Chrispin J, Gilotra NA, et al
    Diagnostic and management strategies in cardiac sarcoidosis.
    Int J Cardiol. 2024;403:131853.
    >> Share

  152. LOPEZ-PALOP R, Carrillo P, Lozano I
    Transient new-onset atrial fibrillaation during acute coronary syndrome: Transient arrhythmia, transient risk?
    Int J Cardiol. 2024 May 14:132163. doi: 10.1016/j.ijcard.2024.132163.
    >> Share

  153. AGUIAR-NEVES I, Sa Carvalho A, Diaz SO, Ribeiro Silva M, et al
    Sex-based differences and risk of recurrence in patients with atrial fibrillation undergoing pulmonary vein isolation.
    Int J Cardiol. 2024;409:132161.
    >> Share

  154. ATTIA A, Hiram R
    Colchicine for the prevention of atrial fibrillation: Why do some studies say 'yes', and others say 'no'?
    Int J Cardiol. 2024;408:132110.
    >> Share

  155. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
    Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
    Int J Cardiol. 2024;402:131819.
    >> Share

    April 2024
  156. KIRCHHOF P, Bakhai A, de Asmundis C, de Groot JR, et al
    Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study.
    Int J Cardiol. 2024 Apr 30:132118. doi: 10.1016/j.ijcard.2024.132118.
    >> Share

  157. MADSEN OJ, Lamberts M, Olesen JB, Hansen ML, et al
    Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013-2021: A nationwide observational study.
    Int J Cardiol. 2024 Apr 26:132098. doi: 10.1016/j.ijcard.2024.132098.
    >> Share

  158. BERNARDINI A, Bindini L, Antonucci E, Berteotti M, et al
    Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation.
    Int J Cardiol. 2024 Apr 22:132088. doi: 10.1016/j.ijcard.2024.132088.
    >> Share

  159. AL A, Babayigit E, Gorenek B
    Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?
    Int J Cardiol. 2024;406:132079.
    >> Share

  160. TIAN X, Zhang N, Korantzopoulos P, Bazoukis G, et al
    Efficacy and safety of colchicine for atrial fibrillation prevention: An updated meta-analysis of randomized controlled trials.
    Int J Cardiol. 2024;406:132068.
    >> Share

  161. PINEIRO AL, Abu-Assi E, Bermudez IG, Caro VN, et al
    Is pre-diabetes a predictor of events in patients with atrial fibrillation?
    Int J Cardiol. 2024 Apr 20:132086. doi: 10.1016/j.ijcard.2024.132086.
    >> Share

  162. MOON I, Park SY, Kim D, Park M, et al
    Incidence of atrial fibrillation in patients with renal infarction: A retrospective cohort analysis of the Korean national health insurance registry.
    Int J Cardiol. 2024 Apr 19:132075. doi: 10.1016/j.ijcard.2024.132075.
    >> Share

  163. TOMER O, Horowitz-Cederboim S, Rivkin D, Meiner V, et al
    Variable clinical expression of a novel FLNC truncating variant in a large family.
    Int J Cardiol. 2024;401:131849.
    >> Share

  164. PETERSEN JK, Butt JH, Yafasova A, Torp-Pedersen C, et al
    Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
    Int J Cardiol. 2024 Apr 6:132017. doi: 10.1016/j.ijcard.2024.132017.
    >> Share

  165. MESSORI A, Mamone D, Rivano M, Romeo MR, et al
    Pulsed-field ablation for paroxysmal atrial fibrillation: An indirect comparison of effectiveness among three proprietary devices conducted in the absence of randomized trials.
    Int J Cardiol. 2024 Apr 5:132025. doi: 10.1016/j.ijcard.2024.132025.
    >> Share

  166. ABU-ASSI E, Castro AL, Fernandez MC, Bermudez IG, et al
    Relative performance evaluation of four bleeding risk scores in atrial fibrillation patients. What does the new DOAC score provide?
    Int J Cardiol. 2024 Apr 3:132018. doi: 10.1016/j.ijcard.2024.132018.
    >> Share

  167. SCHEEL PJ 3RD, Cartella I, Murray B, Gilotra NA, et al
    Role of genetics in inflammatory cardiomyopathy.
    Int J Cardiol. 2024;400:131777.
    >> Share

    March 2024
  168. KARTAS A, Papazoglou AS, Moysidis DV, Despotopoulos S, et al
    Use of apixaban in adults with congenital heart disease and atrial arrhythmias: The PROTECT-AR study.
    Int J Cardiol. 2024 Mar 31:131993. doi: 10.1016/j.ijcard.2024.131993.
    >> Share

  169. ABE K, Kitahara H, Suzuki S, Hiraga T, et al
    Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Int J Cardiol. 2024 Mar 21:131989. doi: 10.1016/j.ijcard.2024.131989.
    >> Share

  170. HUANG S, Joshi A, Shi Z, Wei J, et al
    Combined polygenic scores for ischemic stroke risk factors aid risk assessment of ischemic stroke.
    Int J Cardiol. 2024 Mar 21:131990. doi: 10.1016/j.ijcard.2024.131990.
    >> Share

  171. WENG F, Yan T, Zhu M, Zhu S, et al
    Performance of a non-irrigated bipolar radiofrequency ablation clamp on beating human hearts.
    Int J Cardiol. 2024;399:131749.
    >> Share

  172. YANG X, Chen S, Song H, Shu R, et al
    Association between cardiac conduction block and cardiovascular disease and all-cause mortality: The kailuan study.
    Int J Cardiol. 2024;399:131666.
    >> Share

  173. GUO J, Wang D, Jia J, Zhang J, et al
    Patterns of atrial fibrillation, relevant cardiac structural and functional changes predict functional and cognitive outcomes in patients with ischemic stroke and atrial fibrillation.
    Int J Cardiol. 2024 Mar 13:131966. doi: 10.1016/j.ijcard.2024.131966.
    >> Share

  174. SHI S, Zhao Q, Wu G, Yan H, et al
    Variation and disparity in awareness of atrial fibrillation in China: A national cross-sectional study.
    Int J Cardiol. 2024 Mar 10:131957. doi: 10.1016/j.ijcard.2024.131957.
    >> Share

  175. KREUTZ R, Kloss S, Enders D, Abdelgawwad K, et al
    Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2024 Mar 2:131894. doi: 10.1016/j.ijcard.2024.131894.
    >> Share

  176. LI L, Qian S, Fu JY, Wang ZN, et al
    Comparing safety and efficacy: MemoLefort versus watchman for left atrial appendage closure.
    Int J Cardiol. 2024;398:131641.
    >> Share

  177. VAN DER STUIJT W, Pepplinkhuizen S, de Veld JA, Quast ABE, et al
    Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
    Int J Cardiol. 2024;398:131639.
    >> Share

    February 2024
  178. LESHEM Y, Etan T, Dolev Y, Nikolaevski-Berlin A, et al
    The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab.
    Int J Cardiol. 2024;397:131642.
    >> Share

  179. ENGEL M, Shiel EA, Chelko SP
    Basic and translational mechanisms in inflammatory arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2024;397:131602.
    >> Share

  180. PIERONI M, Ciabatti M, Zocchi C, Tavanti V, et al
    Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis.
    Int J Cardiol. 2024;397:131603.
    >> Share

  181. LIU CM, Chen WS, Chang SL, Hsieh YC, et al
    Use of artificial intelligence and I-score for prediction of recurrence before catheter ablation of atrial fibrillation.
    Int J Cardiol. 2024 Feb 13:131851. doi: 10.1016/j.ijcard.2024.131851.
    >> Share

  182. CHEW DS, Sacks NC, Emden MR, Cyr PL, et al
    Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study.
    Int J Cardiol. 2024 Feb 6:131831. doi: 10.1016/j.ijcard.2024.131831.
    >> Share

  183. ZOU JH, Hua BT, Shao XX, Wang C, et al
    Redefining left bundle branch block from high-density electroanatomical mapping.
    Int J Cardiol. 2024 Feb 4:131830. doi: 10.1016/j.ijcard.2024.131830.
    >> Share

  184. HOU Y, Yang H, Xu Y, Wang K, et al
    Hearing disorders, genetic predisposition, and risk of new-onset atrial fibrillation: A prospective cohort study in the UK biobank.
    Int J Cardiol. 2024 Feb 4:131829. doi: 10.1016/j.ijcard.2024.131829.
    >> Share

    January 2024
  185. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
    Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
    Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
    >> Share

  186. UKITA K, Egami Y, Nohara H, Kawanami S, et al
    Predictors of 30-day survival after emergent percutaneous coronary intervention following ventricular Tachyarrhythmias complicating acute myocardial infarction.
    Int J Cardiol. 2024 Jan 21:131806. doi: 10.1016/j.ijcard.2024.131806.
    >> Share

  187. CORRADO D, Anastasakis A, Basso C, Bauce B, et al
    Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.
    Int J Cardiol. 2024;395:131447.
    >> Share

  188. MUROKE V, Jalanko M, Haukka J, Anttila V, et al
    Long-term outcome after surgical correction of sinus venosus defect in a nationwide register-based cohort study.
    Int J Cardiol. 2024;395:131433.
    >> Share

  189. KOMATSU T, Okumura M, Kida H, Takahashi J, et al
    Thin aortic arch plaque is associated with the development of atrial fibrillation for embolic stroke of undetermined source in patients with an insertable cardiac monitor.
    Int J Cardiol. 2024 Jan 9:131769. doi: 10.1016/j.ijcard.2024.131769.
    >> Share

    December 2023
  190. HIRAM R
    The duration of atrial fibrillation might be associated with right heart disease severity.
    Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
    >> Share

  191. ROTTMANN FA, Abraham H, Welte T, Westermann L, et al
    Atrial fibrillation and survival on a medical intensive care unit.
    Int J Cardiol. 2023 Dec 22:131673. doi: 10.1016/j.ijcard.2023.131673.
    >> Share

  192. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
    Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
    Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
    >> Share

  193. XING Y, Zhang Y, Zhao R, Shi J, et al
    Changes of left atrial morphology and function evaluated with four-dimensional automated left atrial quantification echocardiography in patients with coronary slow flow phenomenon and preserved left ventricular ejection fraction.
    Int J Cardiol. 2023;393:131351.
    >> Share

  194. HU H, Yang J
    Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?
    Int J Cardiol. 2023 Dec 6:131644. doi: 10.1016/j.ijcard.2023.131644.
    >> Share

  195. YAO PC, Fei ZT, Chen M, Mo BF, et al
    Incidence, impact and predictors of residual device patency after left atrial appendage closure with the LACbes device.
    Int J Cardiol. 2023 Dec 6:131640. doi: 10.1016/j.ijcard.2023.131640.
    >> Share

  196. GIANNAKOULAS G, Baroutidou A
    Predicting antepartum arrhythmias in congenital heart disease: A step forward?
    Int J Cardiol. 2023;392:131287.
    >> Share

    November 2023
  197. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
    Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
    Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
    >> Share

  198. CEMIN R, Cappato R
    Lessons derived from post authorisation safety studies (ETNA-AF and XANTUS) on once daily direct oral anticoagulants for atrial fibrillation.
    Int J Cardiol. 2023 Nov 27:131618. doi: 10.1016/j.ijcard.2023.131618.
    >> Share

  199. KAULING RM, Pelosi C, Cuypers JAAE, van den Bosch AE, et al
    Long term outcome after surgical ASD-closure at young age: Longitudinal follow-up up to 50?years after surgery.
    Int J Cardiol. 2023 Nov 27:131616. doi: 10.1016/j.ijcard.2023.131616.
    >> Share

  200. JUNG M, Yang PS, Kim D, Sung JH, et al
    Multimorbidity in atrial fibrillation for clinical implications using the Charlson Comorbidity Index.
    Int J Cardiol. 2023 Nov 22:131605. doi: 10.1016/j.ijcard.2023.131605.
    >> Share

  201. TAYAL B, Rorth R, Kristensen SL, Wissenberg M, et al
    Comparative outcomes in patients with preexisting heart failure to those without heart failure after out-of-hospital cardiac arrest: A nationwide registry study.
    Int J Cardiol. 2023 Nov 18:131595. doi: 10.1016/j.ijcard.2023.131595.
    >> Share

  202. ALEXANDRINO FB, Faaborg-Andersen CC, da Silva-de Abreu A
    Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?
    Int J Cardiol. 2023 Nov 16:131591. doi: 10.1016/j.ijcard.2023.131591.
    >> Share

  203. ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
    Impaired retinal micro-vascular function in patients with atrial fibrillation.
    Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
    >> Share

  204. CEMIN R, Maggioni AP, Boriani G, Di Pasquale G, et al
    Is there a reduced confidence towards direct oral anticoagulants compared to vitamin K antagonists in patients scheduled for an elective electrical cardioversion? The results of the BLITZ-AF study.
    Int J Cardiol. 2023;391:131302.
    >> Share

  205. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
    Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
    Int J Cardiol. 2023;391:131265.
    >> Share

  206. ZORZI A, D'Ascenzi F, Andreini D, Castelletti S, et al
    Interpretation and management of premature ventricular beats in athletes: An expert opinion document of the Italian Society of Sports Cardiology (SICSPORT).
    Int J Cardiol. 2023;391:131220.
    >> Share

  207. XIAO X
    The mechanistic insights into new-onset atrial fibrillation induced by SARS-CoV-2 infection.
    Int J Cardiol. 2023 Nov 11:131587. doi: 10.1016/j.ijcard.2023.131587.
    >> Share

  208. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
    Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
    >> Share

  209. LI ZH, Zhong WF, Qiu CS, Yang P, et al
    Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
    Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
    >> Share

  210. LINDOW T, Mokhtari A, Nystrom A, Koul S, et al
    Comparison of diagnostic accuracy of current left bundle branch block and ventricular pacing ECG criteria for detection of occlusion myocardial infarction.
    Int J Cardiol. 2023 Nov 4:131569. doi: 10.1016/j.ijcard.2023.131569.
    >> Share

  211. KELLNAR A, von Falkenhausen AS, Fichtner S, Sinner M, et al
    Effects of contemporary hard- and software mapping and ablation features on acute and long-term success in premature ventricular complex ablation.
    Int J Cardiol. 2023;390:131269.
    >> Share

  212. ZHU Y, Wang Y, Liu X, Wang Y, et al
    Genetically predicted osteoprotegerin levels and the risk of cardiovascular diseases: A Mendelian randomization study.
    Int J Cardiol. 2023;390:131233.
    >> Share

  213. LEVENTOPOULOS G, Travlos CK, Aronis KN, Anagnostopoulou V, et al
    Safety and efficacy of left bundle branch area pacing compared with right ventricular pacing in patients with bradyarrhythmia and conduction system disorders: Systematic review and meta-analysis.
    Int J Cardiol. 2023;390:131230.
    >> Share

  214. IDIAZABAL-AYESA U, Ramirez-Velez R, Sanz-de la Garza M, Izquierdo M, et al
    Electrocardiographic findings in pediatric versus young-adolescent athletes: A comparative analysis using general international criteria.
    Int J Cardiol. 2023;390:131201.
    >> Share

    October 2023
  215. BRANDES A
    Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
    Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
    >> Share

  216. BICCIRE FG, Lip GYH, Pastori D
    Reply to: The C2HEST and mC2HEST scores to predict the risk of new onset atrial fibrillation after presentation with acute coronary syndrome.
    Int J Cardiol. 2023 Oct 21:131547. doi: 10.1016/j.ijcard.2023.131547.
    >> Share

  217. SERI A, Rabadi A, Baral N, Andi K, et al
    Prevalence of respiratory failure and use of mechanical ventilation in heart failure patients undergoing left atrial appendage occlusion device implantation.
    Int J Cardiol. 2023 Oct 21:131552. doi: 10.1016/j.ijcard.2023.131552.
    >> Share

  218. GUARRACINI F, Maines M, Nappi F, Vitulano G, et al
    Daily and automatic remote monitoring of implantable cardiac monitors: A descriptive analysis of transmitted episodes.
    Int J Cardiol. 2023;389:131199.
    >> Share

  219. GANDAEVA L, Sonicheva-Paterson N, McKenna WJ, Savostyanov K, et al
    Clinical features of pediatric Danon disease and the importance of early diagnosis.
    Int J Cardiol. 2023;389:131189.
    >> Share

  220. ANSARI RAMANDI MM, Yarmohammadi H, Gareb B, Voors AA, et al
    Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: A systematic review and meta-analysis.
    Int J Cardiol. 2023;389:131159.
    >> Share

  221. GAO P, Gao X, Xie B, Tse G, et al
    Aging and atrial fibrillation: A vicious circle.
    Int J Cardiol. 2023 Oct 15:131445. doi: 10.1016/j.ijcard.2023.131445.
    >> Share

  222. MOCKEL M, Pudasaini S, Baberg HT, Levenson B, et al
    Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study.
    Int J Cardiol. 2023 Oct 10:131434. doi: 10.1016/j.ijcard.2023.131434.
    >> Share

    September 2023
  223. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
    Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
    Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
    >> Share

  224. GENNARO N, Ferroni E, Zorzi M, Denas G, et al
    ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAIVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Int J Cardiol. 2023 Sep 16:131369. doi: 10.1016/j.ijcard.2023.131369.
    >> Share

  225. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
    Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
    Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
    >> Share

  226. FUMAGALLI C, Zampieri M, Argiro A, Tassetti L, et al
    Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis.
    Int J Cardiol. 2023 Sep 7:131346. doi: 10.1016/j.ijcard.2023.131346.
    >> Share

  227. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
    Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
    Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
    >> Share

    August 2023
  228. BICCIRE FG, Lip GYH, Pastori D
    Reply to: Prediction scores for new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Two sides of the same coin.
    Int J Cardiol. 2023 Aug 31:131305. doi: 10.1016/j.ijcard.2023.131305.
    >> Share

  229. JESSEN N, Andersen JA, Tayal B, Ostergaard L, et al
    Takotsubo syndrome and stroke risk: A nationwide register-based study.
    Int J Cardiol. 2023 Aug 22:131283. doi: 10.1016/j.ijcard.2023.131283.
    >> Share

    July 2023
  230. PAPAPOSTOLOU S, Kearns J, Costello BT, O'Brien J, et al
    Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source.
    Int J Cardiol. 2023 Jul 25:131215. doi: 10.1016/j.ijcard.2023.131215.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016